{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:18:16Z","timestamp":1780913896139,"version":"3.54.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Programa Presupuestal P016, Anexo 13 del Decreto del Presupuesto de Egresos de la Federaci\u00f3n"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11318-2","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T03:28:28Z","timestamp":1752550108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Patterns of immune recovery in people living with HIV who initiated antiretroviral therapy as late presenters"],"prefix":"10.1186","volume":"25","author":[{"given":"Sandra","family":"Pinto-Cardoso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monserrat","family":"Ch\u00e1vez-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"L\u00f3pez-Filloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"\u00c1vila-R\u00edos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Romero-Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Peralta-Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"issue":"9903","key":"11318_CR1","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","volume":"382","author":"SG Deeks","year":"2013","unstructured":"Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013;382(9903):1525\u201333.","journal-title":"Lancet"},{"issue":"2","key":"11318_CR2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/ije\/dyr164","volume":"41","author":"C Lewden","year":"2012","unstructured":"Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord, Lewden C, Bouteloup V, De Wit S, Sabin C, Mocroft A, et al. All-cause mortality in treated HIV-infected adults with CD4\u2009\u2265\u2009500\/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol. 2012;41(2):433\u201345.","journal-title":"Int J Epidemiol"},{"issue":"3","key":"11318_CR3","first-page":"155","volume":"45","author":"V Bono","year":"2022","unstructured":"Bono V, Augello M, Tincati C, Marchetti G. Failure of CD4\u2009+\u2009T-cell recovery upon Virally-Effective cART: an enduring gap in the Understanding of HIV\u2009+\u2009Immunological non-Responders. New Microbiol. 2022;45(3):155\u201372.","journal-title":"New Microbiol"},{"key":"11318_CR4","doi-asserted-by":"publisher","first-page":"1487565","DOI":"10.3389\/fimmu.2024.1487565","volume":"15","author":"E Saidakova","year":"2024","unstructured":"Saidakova E, Shmagel K, Sieg S, Hunt P. Editorial: immunological non-responders in HIV infection. Front Immunol. 2024;15:1487565.","journal-title":"Front Immunol"},{"issue":"5","key":"11318_CR5","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/QAI.0000000000002157","volume":"82","author":"R Rb-Silva","year":"2019","unstructured":"Rb-Silva R, Goios A, Kelly C, Teixeira P, Jo\u00e3o C, Horta A, et al. Definition of immunological nonresponse to antiretroviral therapy: A systematic review. J Acquir Immune Defic Syndr 1999. 2019;82(5):452\u201361.","journal-title":"J Acquir Immune Defic Syndr 1999"},{"issue":"1","key":"11318_CR6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s40168-024-01815-y","volume":"12","author":"M Tr\u00f8seid","year":"2024","unstructured":"Tr\u00f8seid M, Nielsen SD, Vujkovic-Cvijin I. Gut Microbiome and cardiometabolic comorbidities in people living with HIV. Microbiome. 2024;12(1):106.","journal-title":"Microbiome"},{"issue":"1","key":"11318_CR7","first-page":"56","volume":"23","author":"DV Havlir","year":"2016","unstructured":"Havlir DV, Currier JS. CROI 2015: complications of HIV infection and antiretroviral therapy. Top Antivir Med. 2016;23(1):56\u201365.","journal-title":"Top Antivir Med"},{"issue":"4","key":"11318_CR8","doi-asserted-by":"publisher","first-page":"716","DOI":"10.3390\/jcm10040716","volume":"10","author":"J Portilla-Tamarit","year":"2021","unstructured":"Portilla-Tamarit J, Reus S, Portilla I, Fuster Ruiz-de-Apodaca MJ, Portilla J. Impact of advanced HIV disease on quality of life and mortality in the era of combined antiretroviral treatment. J Clin Med. 2021;10(4):716.","journal-title":"J Clin Med"},{"key":"11318_CR9","doi-asserted-by":"publisher","first-page":"1236460","DOI":"10.3389\/fmicb.2023.1236460","volume":"14","author":"W Zhang","year":"2023","unstructured":"Zhang W, Ruan L. Recent advances in poor HIV immune reconstitution: what will the future look like? Front Microbiol. 2023;14:1236460.","journal-title":"Front Microbiol"},{"key":"11318_CR10","doi-asserted-by":"publisher","first-page":"632119","DOI":"10.3389\/fimmu.2021.632119","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Jiang T, Li A, Li Z, Hou J, Gao M, et al. Adjunct therapy for CD4\u2009+\u2009T-Cell recovery, inflammation and immune activation in people living with HIV: A systematic review and Meta-Analysis. Front Immunol. 2021;12:632119.","journal-title":"Front Immunol"},{"issue":"4","key":"11318_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/JLB.4MR1019-189R","volume":"107","author":"X Yang","year":"2020","unstructured":"Yang X, Su B, Zhang X, Liu Y, Wu H, Zhang T. Incomplete immune reconstitution in HIV\/AIDS patients on antiretroviral therapy: challenges of immunological non-responders. J Leukoc Biol. 2020;107(4):597\u2013612.","journal-title":"J Leukoc Biol"},{"key":"11318_CR12","doi-asserted-by":"publisher","first-page":"1228795","DOI":"10.3389\/fimmu.2023.1228795","volume":"14","author":"S Espineira","year":"2023","unstructured":"Espineira S, Flores-Pi\u00f1as M, Chafino S, Vilad\u00e9s C, Negredo E, Fern\u00e1ndez-Arroyo S, et al. Multi-omics in HIV: searching insights to understand immunological non-response in PLHIV. Front Immunol. 2023;14:1228795.","journal-title":"Front Immunol"},{"issue":"1","key":"11318_CR13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12879-024-09021-9","volume":"24","author":"H Zhao","year":"2024","unstructured":"Zhao H, Feng A, Luo D, Yuan T, Lin YF, Ling X, et al. Factors associated with immunological non-response after ART initiation: a retrospective observational cohort study. BMC Infect Dis. 2024;24(1):138.","journal-title":"BMC Infect Dis"},{"key":"11318_CR14","doi-asserted-by":"publisher","first-page":"1378431","DOI":"10.3389\/fimmu.2024.1378431","volume":"15","author":"X Sun","year":"2024","unstructured":"Sun X, Xie Z, Wu Z, Song M, Zhang Y, Zhang Z, et al. Mechanisms of HIV-immunologic non-responses and research trends based on gut microbiota. Front Immunol. 2024;15:1378431.","journal-title":"Front Immunol"},{"key":"11318_CR15","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.2147\/IDR.S404384","volume":"16","author":"X Tian","year":"2023","unstructured":"Tian X, Xie Y, Chen J, Yin W, Zhao YL, Yao P, et al. Increased microbial translocation is a prognostic biomarker of different immune responses to ART in people living with HIV. Infect Drug Resist. 2023;16:3871\u20138.","journal-title":"Infect Drug Resist"},{"issue":"12","key":"11318_CR16","doi-asserted-by":"publisher","first-page":"e0308859","DOI":"10.1371\/journal.pone.0308859","volume":"19","author":"R Mac Cann","year":"2024","unstructured":"Mac Cann R, Newman E, Devane D, Sabin C, Cotter AG, Landay A, et al. HIV, the gut Microbiome and clinical outcomes, a systematic review. PLoS ONE. 2024;19(12):e0308859.","journal-title":"PLoS ONE"},{"key":"11318_CR17","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1186\/s12889-023-16738-w","volume":"23","author":"W Zhang","year":"2023","unstructured":"Zhang W, Yan J, Luo H, Wang X, Ruan L. Incomplete immune reconstitution and its predictors in people living with HIV in wuhan, China. BMC Public Health. 2023;23:1808.","journal-title":"BMC Public Health"},{"key":"11318_CR18","doi-asserted-by":"crossref","unstructured":"Yan L, Xu K, Xiao Q, Tuo L, Luo T, Wang S et al. Cellular and molecular insights into incomplete immune recovery in HIV\/AIDS patients. Front Immunol. 2023;14. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2023.1152951\/full.\u00a0Cited 2025 Feb 13.","DOI":"10.3389\/fimmu.2023.1152951"},{"key":"11318_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2217\/fmb-2022-0215","volume":"18","author":"SD Zaongo","year":"2023","unstructured":"Zaongo SD, Chen Y. Gut microbiota: a potential key player in boosting immune reconstitution of immunological nonresponders. Future Microbiol. 2023;18:83\u20135.","journal-title":"Future Microbiol"},{"issue":"1","key":"11318_CR20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s40168-024-01925-7","volume":"12","author":"C Boukadida","year":"2024","unstructured":"Boukadida C, Peralta-Prado A, Ch\u00e1vez-Torres M, Romero-Mora K, Rincon-Rubio A, \u00c1vila-R\u00edos S, et al. Alterations of the gut Microbiome in HIV infection highlight human anelloviruses as potential predictors of immune recovery. Microbiome. 2024;12(1):204.","journal-title":"Microbiome"},{"issue":"5","key":"11318_CR21","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1111\/jam.15505","volume":"132","author":"F Amador-Lara","year":"2022","unstructured":"Amador-Lara F, Andrade-Villanueva JF, Vega-Maga\u00f1a N, Pe\u00f1a-Rodr\u00edguez M, Alvarez-Zavala M, Sanchez-Reyes K, et al. Gut microbiota from Mexican patients with metabolic syndrome and HIV infection: an inflammatory profile. J Appl Microbiol. 2022;132(5):3839\u201352.","journal-title":"J Appl Microbiol"},{"issue":"9","key":"11318_CR22","doi-asserted-by":"publisher","first-page":"4830","DOI":"10.3390\/ijms25094830","volume":"25","author":"TA Baltazar-D\u00edaz","year":"2024","unstructured":"Baltazar-D\u00edaz TA, Andrade-Villanueva JF, S\u00e1nchez-\u00c1lvarez P, Amador-Lara F, Holgu\u00edn-Aguirre T, S\u00e1nchez-Reyes K, et al. A Two-Faced gut microbiome: butyrogenic and Proinflammatory Bacteria predominate in the intestinal milieu of people living with HIV from Western Mexico. Int J Mol Sci. 2024;25(9):4830.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"11318_CR23","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3390\/microorganisms11040951","volume":"11","author":"TA Baltazar-D\u00edaz","year":"2023","unstructured":"Baltazar-D\u00edaz TA, Amador-Lara F, Andrade-Villanueva JF, Gonz\u00e1lez-Hern\u00e1ndez LA, Cabrera-Silva RI, S\u00e1nchez-Reyes K, et al. Gut bacterial communities in HIV-Infected individuals with metabolic syndrome: effects of the therapy with integrase strand transfer Inhibitor-Based and protease Inhibitor-Based regimens. Microorganisms. 2023;11(4):951.","journal-title":"Microorganisms"},{"key":"11318_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12950-020-00262-4","volume":"17","author":"M Ruiz-Brise\u00f1o","year":"2020","unstructured":"Ruiz-Brise\u00f1o M, del Arcos-Jim\u00e9nez R, Ratkovich-Gonz\u00e1lez JC, S\u00e1nchez-Reyes S, Gonz\u00e1lez-Hern\u00e1ndez K, Andrade-Villanueva LA. Association of intestinal and systemic inflammatory biomarkers with immune reconstitution in HIV\u2009+\u2009patients on ART. J Inflamm Lond Engl. 2020;17:32.","journal-title":"J Inflamm Lond Engl"},{"issue":"4","key":"11318_CR25","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/QAD.0000000000002458","volume":"34","author":"O Brice\u00f1o","year":"2020","unstructured":"Brice\u00f1o O, Ch\u00e1vez-Torres M, Peralta-Prado A, Garrido-Rodr\u00edguez D, Romero-Mora K, Pinto-Cardoso S, et al. Associations between recent thymic emigrants and CD4\u2009+\u2009T-cell recovery after short-term antiretroviral therapy initiation. AIDS Lond Engl. 2020;34(4):501\u201311.","journal-title":"AIDS Lond Engl"},{"key":"11318_CR26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.coph.2020.09.010","volume":"54","author":"C Rosel-Pech","year":"2020","unstructured":"Rosel-Pech C, Ch\u00e1vez-Torres M, Bekker-M\u00e9ndez VC, Pinto-Cardoso S. Therapeutic avenues for restoring the gut Microbiome in HIV infection. Curr Opin Pharmacol. 2020;54:188\u2013201.","journal-title":"Curr Opin Pharmacol"},{"issue":"4\u20135","key":"11318_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.resmic.2019.03.001","volume":"170","author":"F Cornejo-Granados","year":"2019","unstructured":"Cornejo-Granados F, de la Calder\u00f3n AM, Torres N, Mart\u00ednez-Romero E, Torres J, L\u00f3pez-Vidal Y, et al. Microbiome-MX 2018: microbiota and Microbiome opportunities in mexico, a megadiverse country. Res Microbiol. 2019;170(4\u20135):235\u201341.","journal-title":"Res Microbiol"},{"key":"11318_CR28","doi-asserted-by":"publisher","first-page":"1244473","DOI":"10.3389\/fimmu.2023.1244473","volume":"14","author":"C Rosel-Pech","year":"2023","unstructured":"Rosel-Pech C, Pinto-Cardoso S, Ch\u00e1vez-Torres M, Montufar N, Osuna-Padilla I, \u00c1vila-R\u00edos S, et al. Distinct fecal microbial signatures are linked to sex and chronic immune activation in pediatric HIV infection. Front Immunol. 2023;14:1244473.","journal-title":"Front Immunol"},{"key":"11318_CR29","doi-asserted-by":"publisher","first-page":"43741","DOI":"10.1038\/srep43741","volume":"7","author":"S Pinto-Cardoso","year":"2017","unstructured":"Pinto-Cardoso S, Lozupone C, Brice\u00f1o O, Alva-Hern\u00e1ndez S, T\u00e9llez N, Adriana A, et al. Fecal bacterial communities in treated HIV infected individuals on two antiretroviral regimens. Sci Rep. 2017;7:43741.","journal-title":"Sci Rep"},{"issue":"1","key":"11318_CR30","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12879-019-3867-9","volume":"19","author":"LA Gonz\u00e1lez-Hern\u00e1ndez","year":"2019","unstructured":"Gonz\u00e1lez-Hern\u00e1ndez LA, Ruiz-Brise\u00f1o MDR, S\u00e1nchez-Reyes K, Alvarez-Zavala M, Vega-Maga\u00f1a N, L\u00f3pez-I\u00f1iguez A, et al. Alterations in bacterial communities, SCFA and biomarkers in an elderly HIV-positive and HIV-negative population in Western Mexico. BMC Infect Dis. 2019;19(1):234.","journal-title":"BMC Infect Dis"},{"key":"11318_CR31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1475-2891-11-90","volume":"11","author":"LA Gonz\u00e1lez-Hern\u00e1ndez","year":"2012","unstructured":"Gonz\u00e1lez-Hern\u00e1ndez LA, Jave-Suarez LF, Fafutis-Morris M, Montes-Salcedo KE, Valle-Gutierrez LG, Campos-Loza AE, et al. Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trial. Nutr J. 2012;11:90.","journal-title":"Nutr J"},{"issue":"3","key":"11318_CR32","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.chom.2016.02.011","volume":"19","author":"CL Monaco","year":"2016","unstructured":"Monaco CL, Gootenberg DB, Zhao G, Handley SA, Ghebremichael MS, Lim ES, et al. Altered Virome and bacterial Microbiome in human immunodeficiency Virus-Associated acquired immunodeficiency syndrome. Cell Host Microbe. 2016;19(3):311\u201322.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"11318_CR33","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41385-018-0083-7","volume":"12","author":"Y Guill\u00e9n","year":"2019","unstructured":"Guill\u00e9n Y, Noguera-Julian M, Rivera J, Casadell\u00e0 M, Zevin AS, Rocafort M, et al. Low nadir CD4\u2009+\u2009T-cell counts predict gut dysbiosis in HIV-1 infection. Mucosal Immunol. 2019;12(1):232\u201346.","journal-title":"Mucosal Immunol"},{"key":"11318_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40168-019-0687-5","volume":"7","author":"M Rocafort","year":"2019","unstructured":"Rocafort M, Noguera-Julian M, Rivera J, Pastor L, Guill\u00e9n Y, Langhorst J, et al. Evolution of the gut Microbiome following acute HIV-1 infection. Microbiome. 2019;7:73.","journal-title":"Microbiome"},{"issue":"1","key":"11318_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1468-1293.2010.00857.x","volume":"12","author":"A Antinori","year":"2011","unstructured":"Antinori A, Coenen T, Costagiola D, Dedes N, Ellefson M, Gatell J, et al. Late presentation of HIV infection: a consensus definition. HIV Med. 2011;12(1):61\u20134.","journal-title":"HIV Med"},{"issue":"8","key":"11318_CR36","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, et al. Reproducible, interactive, scalable and extensible Microbiome data science using QIIME 2. Nat Biotechnol. 2019;37(8):852\u20137.","journal-title":"Nat Biotechnol"},{"issue":"7","key":"11318_CR37","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: High-resolution sample inference from illumina amplicon data. Nat Methods. 2016;13(7):581\u20133.","journal-title":"Nat Methods"},{"key":"11318_CR38","doi-asserted-by":"crossref","unstructured":"DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K et al. Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB. Appl Environ Microbiol. 2006;72(7):5069\u201372. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC1489311\/.\u00a0Cited 2020 Apr 28.","DOI":"10.1128\/AEM.03006-05"},{"key":"11318_CR39","unstructured":"Sida CN para la P y C del V y el. gob.mx. Gu\u00eda de Manejo Antirretroviral de las Personas con VIH - M\u00e9xico 2021. Available from: http:\/\/www.gob.mx\/censida\/documentos\/guia-de-manejo-antirretroviral-de-las-personas-con-vih-mexico-2021-297710.\u00a0Cited 2024 Apr 22."},{"issue":"12","key":"11318_CR40","doi-asserted-by":"publisher","first-page":"8228","DOI":"10.1128\/AEM.71.12.8228-8235.2005","volume":"71","author":"C Lozupone","year":"2005","unstructured":"Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol. 2005;71(12):8228\u201335.","journal-title":"Appl Environ Microbiol"},{"issue":"2","key":"11318_CR41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/ismej.2010.133","volume":"5","author":"C Lozupone","year":"2011","unstructured":"Lozupone C, Lladser ME, Knights D, Stombaugh J, Knight R. UniFrac: an effective distance metric for microbial community comparison. ISME J. 2011;5(2):169\u201372.","journal-title":"ISME J"},{"key":"11318_CR42","unstructured":"Sida CN para la P y C del V y el\u00a0gob.mx. Epidemiolog\u00eda Registro Nacional de Casos de VIH y sida. Available from: http:\/\/www.gob.mx\/censida\/documentos\/epidemiologia-registro-nacional-de-casos-de-sida.\u00a0Cited 2025 Feb 27."},{"issue":"5","key":"11318_CR43","doi-asserted-by":"publisher","first-page":"e1004078","DOI":"10.1371\/journal.ppat.1004078","volume":"10","author":"S Serrano-Villar","year":"2014","unstructured":"Serrano-Villar S, Sainz T, Lee SA, Hunt PW, Sinclair E, Shacklett BL, et al. HIV-Infected individuals with low CD4\/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8\u2009+\u2009T cell activation, and increased risk of Non-AIDS morbidity and mortality. PLoS Pathog. 2014;10(5):e1004078.","journal-title":"PLoS Pathog"},{"issue":"5","key":"11318_CR44","first-page":"449","volume":"18","author":"C Torti","year":"2012","unstructured":"Torti C, Prosperi M, Motta D, Digiambenedetto S, Maggiolo F, Paraninfo G, et al. Factors influencing the normalization of CD4\u2009+\u2009T-cell count, percentage and CD4+\/CD8\u2009+\u2009T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2012;18(5):449\u201358.","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"issue":"8","key":"11318_CR45","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/infdis\/jiw263","volume":"214","author":"TB Knudsen","year":"2016","unstructured":"Knudsen TB, Ertner G, Petersen J, M\u00f8ller HJ, Moestrup SK, Eugen-Olsen J, et al. Plasma soluble CD163 level independently predicts All-Cause mortality in HIV-1\u2013Infected individuals. J Infect Dis. 2016;214(8):1198\u2013204.","journal-title":"J Infect Dis"},{"issue":"6","key":"11318_CR46","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/infdis\/jiq118","volume":"203","author":"NG Sandler","year":"2011","unstructured":"Sandler NG, Wand H, Roque A, Law M, Nason MC, Nixon DE, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011;203(6):780\u201390.","journal-title":"J Infect Dis"},{"issue":"11","key":"11318_CR47","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1097\/QAD.0b013e3283471d10","volume":"25","author":"G Marchetti","year":"2011","unstructured":"Marchetti G, Cozzi-Lepri A, Merlini E, Bellistr\u00ec GM, Castagna A, Galli M, et al. Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4\u2009+\u2009cell count. AIDS. 2011;25(11):1385.","journal-title":"AIDS"},{"issue":"10","key":"11318_CR48","doi-asserted-by":"publisher","first-page":"e20790","DOI":"10.1016\/j.heliyon.2023.e20790","volume":"9","author":"XY Guo","year":"2023","unstructured":"Guo XY, Guo YT, Wang ZR, Jiao YM, Hu Y, Fan LN, et al. Severe intestinal barrier damage in HIV-infected immunological non-responders. Heliyon. 2023;9(10):e20790.","journal-title":"Heliyon"},{"issue":"4","key":"11318_CR49","doi-asserted-by":"publisher","first-page":"e0214735","DOI":"10.1371\/journal.pone.0214735","volume":"14","author":"V Subramanya","year":"2019","unstructured":"Subramanya V, McKay HS, Brusca RM, Palella FJ, Kingsley LA, Witt MD, et al. Inflammatory biomarkers and subclinical carotid atherosclerosis in HIV-infected and HIV-uninfected men in the multicenter AIDS cohort study. PLoS ONE. 2019;14(4):e0214735.","journal-title":"PLoS ONE"},{"issue":"8","key":"11318_CR50","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/infdis\/jir520","volume":"204","author":"TH Burdo","year":"2011","unstructured":"Burdo TH, Lo J, Abbara S, Wei J, DeLelys ME, Preffer F, et al. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-Infected patients. J Infect Dis. 2011;204(8):1227\u201336.","journal-title":"J Infect Dis"},{"issue":"1","key":"11318_CR51","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12866-020-02074-1","volume":"21","author":"Y Xie","year":"2021","unstructured":"Xie Y, Sun J, Wei L, Jiang H, Hu C, Yang J, et al. Altered gut microbiota correlate with different immune responses to HAART in HIV-infected individuals. BMC Microbiol. 2021;21(1):11.","journal-title":"BMC Microbiol"},{"key":"11318_CR52","doi-asserted-by":"publisher","first-page":"639291","DOI":"10.3389\/fimmu.2021.639291","volume":"12","author":"G Ancona","year":"2021","unstructured":"Ancona G, Merlini E, Tincati C, Barassi A, Calcagno A, Augello M, et al. Long-Term suppressive cART is not sufficient to restore intestinal permeability and gut microbiota compositional changes. Front Immunol. 2021;12:639291.","journal-title":"Front Immunol"},{"issue":"4","key":"11318_CR53","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/infdis\/jiaa714","volume":"225","author":"MH Meyer-Myklestad","year":"2022","unstructured":"Meyer-Myklestad MH, Medhus AW, Lorvik KB, Seljeflot I, Hansen SH, Holm K, et al. Human immunodeficiency Virus\u2013Infected immunological nonresponders have Colon-Restricted gut mucosal immune dysfunction. J Infect Dis. 2022;225(4):661\u201374.","journal-title":"J Infect Dis"},{"issue":"1","key":"11318_CR54","first-page":"168","volume":"9","author":"K Nganou-Makamdop","year":"2024","unstructured":"Nganou-Makamdop K, Douek DC. The gut and the translocated microbiomes in HIV infection: current concepts and future avenues. Pathog Immun. 2024;9(1):168\u201394.","journal-title":"Pathog Immun"},{"issue":"15","key":"11318_CR55","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1016\/j.cell.2021.05.023","volume":"184","author":"K Nganou-Makamdop","year":"2021","unstructured":"Nganou-Makamdop K, Talla A, Sharma AA, Darko S, Ransier A, Laboune F, et al. Translocated Microbiome composition determines immunological outcome in treated HIV infection. Cell. 2021;184(15):3899\u2013e391416.","journal-title":"Cell"},{"key":"11318_CR56","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s40168-024-01825-w","volume":"12","author":"JM Brenchley","year":"2024","unstructured":"Brenchley JM, Serrano-Villar S. From dysbiosis to defense: Harnessing the gut Microbiome in HIV\/SIV therapy. Microbiome. 2024;12:113.","journal-title":"Microbiome"},{"issue":"1","key":"11318_CR57","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1038\/s41467-020-16222-8","volume":"11","author":"I Vujkovic-Cvijin","year":"2020","unstructured":"Vujkovic-Cvijin I, Sortino O, Verheij E, Sklar J, Wit FW, Kootstra NA, et al. HIV-associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases. Nat Commun. 2020;11(1):2448.","journal-title":"Nat Commun"},{"issue":"18","key":"11318_CR58","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1097\/QAD.0000000000000869","volume":"29","author":"P Nowak","year":"2015","unstructured":"Nowak P, Troseid M, Avershina E, Barqasho B, Neogi U, Holm K, et al. Gut microbiota diversity predicts immune status in HIV-1 infection. AIDS Lond Engl. 2015;29(18):2409\u201318.","journal-title":"AIDS Lond Engl"},{"issue":"11","key":"11318_CR59","doi-asserted-by":"publisher","first-page":"113336","DOI":"10.1016\/j.celrep.2023.113336","volume":"42","author":"I Sereti","year":"2023","unstructured":"Sereti I, Verburgh ML, Gifford J, Lo A, Boyd A, Verheij E, et al. Impaired gut microbiota-mediated short-chain fatty acid production precedes morbidity and mortality in people with HIV. Cell Rep. 2023;42(11):113336.","journal-title":"Cell Rep"},{"key":"11318_CR60","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3389\/fmicb.2018.01451","volume":"9","author":"W Lu","year":"2018","unstructured":"Lu W, Feng Y, Jing F, Han Y, Lyu N, Liu F, et al. Association between gut microbiota and CD4 recovery in HIV-1 infected patients. Front Microbiol. 2018;9:1451.","journal-title":"Front Microbiol"},{"key":"11318_CR61","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41426-018-0117-y","volume":"7","author":"Y Ji","year":"2018","unstructured":"Ji Y, Zhang F, Zhang R, Shen Y, Liu L, Wang J, et al. Changes in intestinal microbiota in HIV-1-infected subjects following cART initiation: influence of CD4\u2009+\u2009T cell count. Emerg Microbes Infect. 2018;7:113.","journal-title":"Emerg Microbes Infect"},{"key":"11318_CR62","doi-asserted-by":"publisher","first-page":"14277","DOI":"10.1038\/s41598-018-32585-x","volume":"8","author":"SC Lee","year":"2018","unstructured":"Lee SC, Chua LL, Yap SH, Khang TF, Leng CY, Raja Azwa RI, et al. Enrichment of gut-derived Fusobacterium is associated with suboptimal immune recovery in HIV-infected individuals. Sci Rep. 2018;8:14277.","journal-title":"Sci Rep"},{"key":"11318_CR63","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ebiom.2016.01.032","volume":"5","author":"M Noguera-Julian","year":"2016","unstructured":"Noguera-Julian M, Rocafort M, Guill\u00e9n Y, Rivera J, Casadell\u00e0 M, Nowak P, et al. Gut microbiota linked to sexual preference and HIV infection. EBioMedicine. 2016;5:135\u201346.","journal-title":"EBioMedicine"},{"issue":"1","key":"11318_CR64","doi-asserted-by":"publisher","first-page":"2214250","DOI":"10.1080\/22221751.2023.2214250","volume":"12","author":"Y Ge","year":"2023","unstructured":"Ge Y, Zhou Y, Liu Y, Lu J, Qiu T, Shi LE, et al. Immune reconstitution efficacy after combination antiretroviral therapy in male HIV-1 infected patients with homosexual and heterosexual transmission. Emerg Microbes Infect. 2023;12(1):2214250.","journal-title":"Emerg Microbes Infect"},{"issue":"15","key":"11318_CR65","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1097\/QAD.0000000000003695","volume":"37","author":"V Kouamou","year":"2023","unstructured":"Kouamou V, Gundidza P, Ndhlovu CE, Makadzange AT. Factors associated with CD4\u2009+\u2009cell count recovery among males and females with advanced HIV disease. AIDS. 2023;37(15):2311.","journal-title":"AIDS"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11318-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11318-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11318-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T10:43:37Z","timestamp":1757241817000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11318-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11318"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11318-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was approved by the ethics committee of the Instituto Nacional de Enfermedades Respiratorias (INER), Ciudad de M\u00e9xico, M\u00e9xico, under protocol number C59-15 and C15-16; and was conducted according to the principles expressed in the Declaration of Helsinki. All individuals were adults (over 18 years old). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"917"}}